About Us

Our Team


About Us

Jenene Thomas Communications, LLC is a dedicated biopharmaceutical advisory firm that specializes in designing and executing fully integrated Investor Relations, Communications and Corporate Strategy programs with the mission of helping clients achieve their near and long term goals while building visibility and establishing credibility.

With nearly 20 years of in-house biotech investor relations, including C-level  experience, the company is committed to building concise, fundamental programs that deliver results. 

The company’s namesake and founder, along with her highly experienced team, guides the firm with her multi-national, pre-IPO, start-up, micro-cap/small-cap and turnaround IR/PR expertise and has led numerous successful private and public financings, totaling over $450 million.

Jenene Thomas Communications applies best practices with creativity while leveraging a deep network of key life science decision makers to pursue its commitment of achieving each client’s mission and vision.

Our firm welcomes the opportunity to discuss and understand your needs to help build messaging platforms, develop momentum and drive value for your company.